Josh Cohen
Josh Cohen is the Co-CEO and Co-Founder at Amylyx Pharmaceuticals Inc. where he has invented and developed AMX0035 and brought it through clinical trials with the help of Justin Klee his co-founder and the other Co-CEO at Amylyx as well as with help from their team and the ALS and Alzheimer's Communities who have guided us and advised us at every step of the way....
N/A
Technology
N/A
Founded
N/A
Employees
N/A
Industry
Visual (Placeholder)
Profile Information
Name
Josh Cohen
Industry
N/A
Technology
N/A
Location
USA
Founded
N/A
Employees
N/A
Category
Entrepreneurs
Contact Information
Email
N/A
Phone
N/A
Address
N/A